Topics
Gliomas | Etiopathogenesis | CDKN2A/B deletion
Home > Publications > Topics > Gliomas > Etiopathogenesis > CDKN2A/B deletion
Wetzel EA, Nohman AI, Hsieh AL, Reuss D, Unterberg AW, Eyüpoglu
IY, Hua L, Youssef G, Wen PY, Cahill DP, Jungk C, Juratli TA,
Miller JJ.
A multi-center,
clinical analysis of IDH-mutant
gliomas, WHO Grade 4: implications for prognosis
and clinical trial design.
J
Neurooncol. 2024 Oct 21. doi:
10.1007/s11060-024-04852-7. PMID:
39432026. Observational study. ˍ